42 Martin Bachmann et al., “The Influence of Antigen Organization on B Cell Responsiveness”, Science 262 (1993), 1448–1451.

43 Tazio Storni et al., “Nonmethylated CG Motifs Packaged into Viruslike Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects”, Journal of Immunology 172 (2004), 1777–1785.

44 Y. Sato et al., “Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization”, Science 273 (1996), 352354; M. Roman et al., “Immunostimulatory DNA Sequences Function as T Helper-1-Promoting Adjuvants “Nature Medicine 3 (1997), 849–854.

45 David Broide et al., “Immunostimulatory DNA Sequences Inhibit IL-5, Eosinophilic Inflammation and Airway Hyperresponsiveness in Mice”, Journal of Immunology 161 (1998), 7054–7062; David Broide et al., “Systemic Administration of Immunostimulatory DNA Sequences Mediates Reversible Inhibition of TH2 Responses in a Mouse Model of Asthma”, Journal of Clinical Immunology 21 (2001), 175–182; Arash Ronaghy et al., “Immunostimulatory DNA Sequences Influence the Course of Adjuvant Arthritis”, Journal of Immunology 168 (2002), 51–56; Daniel Rachmilewitz et al., “Immunostimulatory DNA Ameliorates Experimental and Spontaneous Murine Colitis”, Gastroenterology 122 (2002), 1428–1441; Omar Duramad et al., “Inhibitors of TLR-9 Act on Multiple Cell Subsets in Mouse and Man In Vitro and Prevent Death In Vivo from Systemic Inflammation”, Journal of Immunology 174 (2004), 5193–5200; Franck Barrat et al., “Nucleic Acids of Mammalian Origin Can Act as Endogenous Ligands for Tolllike Receptors and May Promote Systemic Lupus Erythematosus”, Journal of Experimental Microbiology 202 (2005), 1131–1139.

46 Peter Creticos et al., “Immunotherapy with a Ragweed-toll-like Receptor 9 Agonist Vaccine for Allergic Rhinitis”, New England Journal of Medicine 355 (2006), 1445–1455.